{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:37:45Z","timestamp":1787027865409,"version":"build-2736575974"},"reference-count":375,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["284\/19"],"award-info":[{"award-number":["284\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006221","name":"United States - Israel Binational Science Foundation","doi-asserted-by":"publisher","award":["2017118"],"award-info":[{"award-number":["2017118"]}],"id":[{"id":"10.13039\/100006221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001736","name":"German-Israeli Foundation for Scientific Research and Development","doi-asserted-by":"publisher","award":["1-1425-415.13\/2017"],"award-info":[{"award-number":["1-1425-415.13\/2017"]}],"id":[{"id":"10.13039\/501100001736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Multiple neurodegenerative diseases (NDDs) such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington\u2019s disease (HD) are being suggested to have common cellular and molecular pathological mechanisms, characterized mainly by protein misfolding and aggregation. These large inclusions, most likely, represent an end stage of a molecular cascade; however, the soluble misfolded proteins, which take part in earlier steps of this cascade, are the more toxic players. These pathological proteins, which characterize each specific disease, lead to the selective vulnerability of different neurons, likely resulting from a combination of different intracellular mechanisms, including mitochondrial dysfunction, ER stress, proteasome inhibition, excitotoxicity, oxidative damage, defects in nucleocytoplasmic transport, defective axonal transport and neuroinflammation. Damage within these neurons is enhanced by damage from the nonneuronal cells, via inflammatory processes that accelerate the progression of these diseases. In this review, while acknowledging the hallmark proteins which characterize the most common NDDs; we place specific focus on the common overlapping mechanisms leading to disease pathology despite these different molecular players and discuss how this convergence may occur, with the ultimate hope that therapies effective in one disease may successfully translate to another.<\/jats:p>","DOI":"10.3390\/cells10092438","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T21:38:12Z","timestamp":1631828292000},"page":"2438","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration"],"prefix":"10.3390","volume":"10","author":[{"given":"Shirel","family":"Argueti-Ostrovsky","sequence":"first","affiliation":[{"name":"Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9988-0022","authenticated-orcid":false,"given":"Leenor","family":"Alfahel","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Kahn","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-7653","authenticated-orcid":false,"given":"Adrian","family":"Israelson","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/539179a","article-title":"Neurodegenerative diseases","volume":"539","author":"Heemels","year":"2016","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature20414","article-title":"Defects in trafficking bridge Parkinson\u2019s disease pathology and genetics","volume":"539","author":"Abeliovich","year":"2016","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature20412","article-title":"The road to restoring neural circuits for the treatment of Alzheimer\u2019s disease","volume":"539","author":"Canter","year":"2016","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: From genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","year":"2016","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Halliwell, B., and Gutteridge, J.M.C. (2015). Free Radicals in Biology and Medicine, Oxford University Press. [5th ed.].","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pediatrneurol.2003.10.001","article-title":"Selective vulnerability in the developing central nervous system","volume":"30","author":"McQuillen","year":"2004","journal-title":"Pediatr. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The Role of Oxidative Stress in Neurodegenerative Diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","article-title":"Oxidative damage to macromolecules in human Parkinson disease and the rotenone model","volume":"62","author":"Sanders","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fncel.2019.00346","article-title":"A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS","volume":"13","author":"Argueti","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuron.2010.07.019","article-title":"Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS","volume":"67","author":"Israelson","year":"2010","journal-title":"Neuron"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","article-title":"Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria","volume":"43","author":"Liu","year":"2004","journal-title":"Neuron"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acschemneuro.7b00140","article-title":"Misfolded SOD1 Accumulation and Mitochondrial Association Contribute to the Selective Vulnerability of Motor Neurons in Familial ALS: Correlation to Human Disease","volume":"8","author":"Kahn","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tcb.2016.05.004","article-title":"Principles and Properties of Stress Granules","volume":"26","author":"Protter","year":"2016","journal-title":"Trends Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/bioinformatics\/bti537","article-title":"FoldIndex: A simple tool to predict whether a given protein sequence is intrinsically unfolded","volume":"21","author":"Prilusky","year":"2005","journal-title":"Bioinformatics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1073\/pnas.1119366109","article-title":"De novo design of synthetic prion domains","volume":"109","author":"Toombs","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jmb.2020.03.004","article-title":"Liquid-Liquid Phase Separation and Its Mechanistic Role in Pathological Protein Aggregation","volume":"432","author":"Babinchak","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cell.2018.03.025","article-title":"Stress Granule Assembly Disrupts Nucleocytoplasmic Transport","volume":"173","author":"Zhang","year":"2018","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","article-title":"TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD","volume":"21","author":"Chou","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_25","first-page":"4103","article-title":"FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins","volume":"27","author":"Steyaert","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1038\/s41467-019-11837-y","article-title":"Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis","volume":"10","author":"Giampetruzzi","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer\u2019s Disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2017.03.023","article-title":"Mutant Huntingtin Disrupts the Nuclear Pore Complex","volume":"94","author":"Grima","year":"2017","journal-title":"Neuron"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2017.03.032","article-title":"Huntington\u2019s Disease: Nuclear Gatekeepers Under Attack","volume":"94","author":"Veldman","year":"2017","journal-title":"Neuron"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/nan.12592","article-title":"Invited Review: The role of prion-like mechanisms in neurodegenerative diseases","volume":"46","author":"Jaunmuktane","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.3457","article-title":"Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases","volume":"20","author":"Guo","year":"2014","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nbd.2016.08.007","article-title":"In Vitro prion-like behaviour of TDP-43 in ALS","volume":"96","author":"Smethurst","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrn2786","article-title":"Prion-like mechanisms in neurodegenerative diseases","volume":"11","author":"Frost","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1073\/pnas.0607423103","article-title":"Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis","volume":"103","author":"Beers","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Yamanaka","year":"2006","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","article-title":"Mouse model of multiple system atrophy \u03b1-synuclein expression in oligodendrocytes causes glial and neuronal degeneration","volume":"45","author":"Yazawa","year":"2005","journal-title":"Neuron"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/stem.3309","article-title":"Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models","volume":"39","author":"Lehtonen","year":"2021","journal-title":"Stem Cells"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41582-019-0257-2","article-title":"Axonal transport and neurological disease","volume":"15","author":"Sleigh","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.tcb.2013.08.007","article-title":"Releasing the brake: Restoring fast axonal transport in neurodegenerative disorders","volume":"23","author":"Hinckelmann","year":"2013","journal-title":"Trends Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuron.2014.10.019","article-title":"Axonal Transport: Cargo-Specific Mechanisms of Motility and Regulation","volume":"84","author":"Maday","year":"2014","journal-title":"Neuron"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer\u2019s Disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nbd.2017.02.004","article-title":"Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?","volume":"105","author":"Hafezparast","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","article-title":"Axon pathology in Parkinson\u2019s disease and Lewy body dementia hippocampus contains \u03b1-, \u03b2-, and \u03b3-synuclein","volume":"96","author":"Galvin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.sbi.2019.06.003","article-title":"Imaging of post-mortem human brain tissue using electron and X-ray microscopy","volume":"58","author":"Lewis","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","article-title":"Protein misfolding in neurodegenerative diseases: Implications and strategies","volume":"6","author":"Sweeney","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.semcdb.2015.03.003","article-title":"Molecular chaperones and neuronal proteostasis","volume":"Volume 40","author":"Smith","year":"2015","journal-title":"Seminars in Cell and Developmental Biology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","article-title":"Molecular Chaperone Functions in Protein Folding and Proteostasis","volume":"82","author":"Kim","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41419-017-0130-4","article-title":"MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: Implications for familial ALS","volume":"9","author":"Shvil","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(16)00099-5","article-title":"Heat shock proteins as potential targets for protective strategies in neurodegeneration","volume":"15","author":"Kampinga","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1074\/jbc.REV118.002806","article-title":"Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling","volume":"294","author":"Genest","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1515\/bmc-2018-0009","article-title":"Small heat shock proteins and neurodegeneration: Recent developments","volume":"9","author":"Kourtis","year":"2018","journal-title":"Biomol. Concepts"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1083\/jcb.201906047","article-title":"Protein quality control in the secretory pathway","volume":"218","author":"Sun","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fnmol.2017.00119","article-title":"Protein Quality Control and the Amyotrophic Lateral Sclerosis\/Frontotemporal Dementia Continuum","volume":"10","author":"Shahheydari","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcell.2018.00128","article-title":"Crosstalk between Mammalian Autophagy and the Ubiquitin-Proteasome System","volume":"6","author":"Kocaturk","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409238.2014.959889","article-title":"Ubiquitin-dependent protein degradation at the yeast endoplasmic reticulum and nuclear envelope","volume":"50","author":"Zattas","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.tibs.2019.04.007","article-title":"Ubiquitin Signaling and Degradation of Aggregate-Prone Proteins","volume":"44","author":"Galves","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.arr.2018.11.006","article-title":"Targeting the proteostasis network in Huntington\u2019s disease","volume":"49","author":"Soares","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1038\/s41467-018-05273-7","article-title":"A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy","volume":"9","author":"Chitiprolu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e13136","DOI":"10.1111\/acel.13136","article-title":"The involvement of stress granules in aging and aging-associated diseases","volume":"19","author":"Cao","year":"2020","journal-title":"Aging Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"ref_66","unstructured":"(2021, September 04). Alzheimers Dementia. 2020 Alzheimer\u2019s Disease Facts and Figures. Available online: https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/full\/10.1002\/alz.12068."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1515\/revneuro-2016-0086","article-title":"Factors underlying cognitive decline in old age and Alzheimer\u2019s disease: The role of the hippocampus","volume":"28","author":"Jaroudi","year":"2017","journal-title":"Rev. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer\u2019s disease","volume":"15","author":"Jahn","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.pmbts.2019.07.002","article-title":"In search of pathogenic amyloid \u03b2-peptide in familial Alzheimer\u2019s disease","volume":"168","author":"Wolfe","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.3233\/JAD-179903","article-title":"Brain Aging and Late-Onset Alzheimer\u2019s Disease: A Matter of Increased Amyloid or Reduced Energy?","volume":"64","author":"Mecocci","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","article-title":"Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer\u2019s Disease","volume":"29","author":"Pickett","year":"2019","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s Disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_77","first-page":"5","article-title":"Amyloid-beta Alzheimer targets\u2014Protein processing, lipid rafts, and amyloid-beta pores","volume":"89","author":"Arbor","year":"2016","journal-title":"Yale J. Boil. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/156720510790274428","article-title":"Familial Alzheimers Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-\u03b2 Protein Precursor Generated by \u03b2-Secretase Cleavage","volume":"7","author":"Zhang","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrn1495","article-title":"Strategies for disease modification in Alzheimer\u2019s disease","volume":"5","author":"Citron","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","article-title":"A systemic view of Alzheimer disease\u2014Insights from amyloid-\u03b2 metabolism beyond the brain","volume":"13","author":"Wang","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain\u2014Implications for Alzheimer disease","volume":"11","author":"Carare","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00401-014-1296-9","article-title":"Pyroglutamylated amyloid-\u03b2 is associated with hyperphosphorylated tau and severity of Alzheimer\u2019s disease","volume":"128","author":"Mandler","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"29645","DOI":"10.1074\/jbc.R800022200","article-title":"The A\u03b2Cs of A\u03b2-cleaving Proteases","volume":"283","author":"Leissring","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"PE1","DOI":"10.1126\/sageke.2003.3.pe1","article-title":"Alzheimer\u2019s Disease, Neuropeptides, Neuropeptidase, and Amyloid- Peptide Metabolism","volume":"2003","author":"Saito","year":"2003","journal-title":"Sci. Aging Knowl. Environ."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/glia.23943","article-title":"Amyloid-\u03b2 impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer\u2019s disease","volume":"69","author":"Jimenez","year":"2021","journal-title":"Glia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","article-title":"Clearance of Amyloid Beta and Tau in Alzheimer\u2019s Disease: From Mechanisms to Therapy","volume":"34","author":"Xin","year":"2018","journal-title":"Neurotox. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/187152710791012071","article-title":"Microglia and Inflammation in Alzheimers Disease","volume":"9","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","article-title":"Cerebral Amyloid Angiopathy: Amyloid \u03b2 Accumulates in Putative Interstitial Fluid Drainage Pathways in Alzheimer\u2019s Disease","volume":"153","author":"Weller","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jnc.13632","article-title":"The amyloid cascade hypothesis: Are we poised for success or failure?","volume":"139","author":"Karran","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3389\/fneur.2019.00980","article-title":"Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer\u2019s Disease: Similarities and Differences","volume":"10","author":"Katsumoto","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205014666170417111859","article-title":"Tau in Alzheimer\u2019s Disease: Mechanisms and Therapeutic Strategies","volume":"15","author":"Gao","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"ref_92","first-page":"289","article-title":"The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"47","author":"Armstrong","year":"2009","journal-title":"Folia Neuropathol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","article-title":"Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration","volume":"33","author":"Wang","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer Disease and Related Tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fnagi.2018.00027","article-title":"Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer\u2019s Disease","volume":"10","author":"Zhou","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1074\/jbc.RA120.012587","article-title":"Truncation of Tau selectively facilitates its pathological activities","volume":"295","author":"Gu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2005.03181.x","article-title":"Sequestosome 1\/p62 shuttles polyubiquitinated tau for proteasomal degradation","volume":"94","author":"Babu","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.bbadis.2014.05.029","article-title":"Axotrophin\/MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein In Vitro impairing microtubule binding","volume":"1842","author":"Flach","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddh083","article-title":"CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation","volume":"13","author":"Petrucelli","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"595532","DOI":"10.3389\/fneur.2020.595532","article-title":"Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation","volume":"11","author":"Alquezar","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Reddy, P.H., and Oliver, D.M. (2019). Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer\u2019s Disease. Cells, 8.","DOI":"10.3390\/cells8050488"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2019.03.016","article-title":"Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer\u2019s disease pathogenesis","volume":"703","author":"Cao","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: Inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/pri.22118","article-title":"Alzheimer disease: A tale of two prions","volume":"7","author":"Nussbaum","year":"2013","journal-title":"Prion"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"697913","DOI":"10.3389\/fmolb.2021.697913","article-title":"The Mitochondrial Hsp90 TRAP1 and Alzheimer\u2019s Disease","volume":"8","author":"Dekker","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Rowles, J., Keane, K., Heck, T.G., Cruzat, V., Verdile, G., and Newsholme, P. (2020). Are Heat Shock Proteins an Important Link between Type 2 Diabetes and Alzheimer Disease?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218204"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jmb.2008.09.063","article-title":"Hsp104 Targets Multiple Intermediates on the Amyloid Pathway and Suppresses the Seeding Capacity of A\u03b2 Fibrils and Protofibrils","volume":"384","author":"Arimon","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Zatsepina, O., Evgen\u2019Ev, M., and Garbuz, D. (2021). Role of a Heat Shock Transcription Factor and the Major Heat Shock Protein Hsp70 in Memory Formation and Neuroprotection. Cells, 10.","DOI":"10.3390\/cells10071638"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12079-014-0243-9","article-title":"Heat shock proteins in neurodegenerative disorders and aging","volume":"8","author":"Leak","year":"2014","journal-title":"J. Cell Commun. Signal."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer\u2019s disease: Clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-170424","article-title":"Memantine for Alzheimer\u2019s Disease: An Updated Systematic Review and Meta-analysis","volume":"60","author":"Kishi","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(19)30480-6","article-title":"A resurrection of aducanumab for Alzheimer\u2019s disease","volume":"19","author":"Schneider","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801\u2014The first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/13543784.2019.1619694","article-title":"Tau immunotherapies for Alzheimer\u2019s disease","volume":"28","author":"Hoskin","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"112915","DOI":"10.1016\/j.ejmech.2020.112915","article-title":"Small molecule therapeutics for tauopathy in Alzheimer\u2019s disease: Walking on the path of most resistance","volume":"209","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An Essay on the Shaking Palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson Pandemic\u2014A Call to Action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"104782","DOI":"10.1016\/j.nbd.2020.104782","article-title":"Genetics of Parkinson\u2019s disease: An introspection of its journey towards precision medicine","volume":"137","author":"Kim","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/bmb\/ldl018","article-title":"Parkinson\u2019s disease and pesticide exposures","volume":"79-80","author":"Dick","year":"2006","journal-title":"Br. Med Bull."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of parkinson\u2019s disease: Dopamine, vesicles and \u03b1-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of Toxic alpha-Synuclein Oligomer within Endoplasmic Reticulum Occurs in alpha-Synucleinopathy In Vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","article-title":"Cell-produced \u03b1-synuclein oligomers are targeted to, and impair, the 26S proteasome","volume":"31","author":"Emmanouilidou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1440-1789.2001.00403.x","article-title":"The cellular pathology of Parkinson\u2019s disease","volume":"21","author":"Takahashi","year":"2001","journal-title":"Neuropathology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/brain\/awv040","article-title":"Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain","volume":"138","author":"Roberts","year":"2015","journal-title":"Brain"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In Vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"[alpha]-Synuclein Locus Triplication Causes Parkinson\u2019s Disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138920309789351921","article-title":"Biophysics of Parkinsons Disease: Structure and Aggregation of \u03b1-Synuclein","volume":"10","author":"Uversky","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmb.2009.05.066","article-title":"Multiple Tight Phospholipid-Binding Modes of \u03b1-Synuclein Revealed by Solution NMR Spectroscopy","volume":"390","author":"Bodner","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e00592","DOI":"10.7554\/eLife.00592","article-title":"Native \u03b1-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2","volume":"2","author":"Diao","year":"2013","journal-title":"eLife"},{"key":"ref_135","first-page":"REVIEWS3002","article-title":"The synucleins","volume":"3","author":"George","year":"2002","journal-title":"Genome Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1091\/mbc.e07-08-0827","article-title":"\u03b1-Synuclein\u2013induced Aggregation of Cytoplasmic Vesicles in Saccharomyces cerevisiae","volume":"19","author":"Soper","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi0341152","article-title":"Nuclear localization of alpha-synuclein and its interaction with histones","volume":"42","author":"Goers","year":"2003","journal-title":"Biochemistry"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12035-012-8328-z","article-title":"Recent Advances in \u03b1-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson\u2019s Disease","volume":"47","author":"Guerrero","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1038\/ncomms8314","article-title":"Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation","volume":"6","author":"Dettmer","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1523\/JNEUROSCI.6194-10.2011","article-title":"Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family","volume":"31","author":"Anwar","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 Is the Dominant Pathological Modification of \u03b1-Synuclein in Familial and Sporadic Lewy Body Disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","article-title":"Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits -Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions","volume":"30","author":"Paleologou","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K\u2013resistant hyperphosphorylated \u03b1-synuclein in aged transgenic mice with locomotor deterioration and in human \u03b1-synucleinopathies","volume":"110","author":"Neumann","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive Phosphorylation of the Parkinson\u2019s Disease Associated \u03b1-Synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"26515","DOI":"10.1074\/jbc.M003542200","article-title":"Synucleins Are a Novel Class of Substrates for G Protein-coupled Receptor Kinases","volume":"275","author":"Pronin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1074\/jbc.C800206200","article-title":"Polo-like Kinase 2 (PLK2) Phosphorylates \u03b1-Synuclein at Serine 129 in Central Nervous System","volume":"284","author":"Inglis","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1523\/JNEUROSCI.0482-05.2005","article-title":"Alpha-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells","volume":"25","author":"Smith","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"E3945","DOI":"10.1073\/pnas.1309991110","article-title":"Polo-like kinase 2 regulates selective autophagic alpha-synuclein clearance and suppresses its toxicity In Vivo","volume":"110","author":"Oueslati","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-011-0815-1","article-title":"Changes in the solubility and phosphorylation of \u03b1-synuclein over the course of Parkinson\u2019s disease","volume":"121","author":"Zhou","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neuroscience.2012.01.028","article-title":"Lewy-like aggregation of \u03b1-synuclein reduces protein phosphatase 2A activity In Vitro and In Vivo","volume":"207","author":"Wu","year":"2012","journal-title":"Neuroscience"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41374-019-0195-z","article-title":"Transmission of \u03b1-synuclein seeds in neurodegenerative disease: Recent developments","volume":"99","author":"Karpowicz","year":"2019","journal-title":"Lab. Investig."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"a023630","DOI":"10.1101\/cshperspect.a023630","article-title":"Potential Pathways of Abnormal Tau and \u03b1-Synuclein Dissemination in Sporadic Alzheimer\u2019s and Parkinson\u2019s Diseases","volume":"8","author":"Braak","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrneurol.2010.145","article-title":"Cell-to-cell transmission of non-prion protein aggregates","volume":"6","author":"Lee","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(87)90827-0","article-title":"Raised Cerebrospinal-Fluid Copper Concentration in Parkinson\u2019s Disease","volume":"330","author":"Pall","year":"1987","journal-title":"Lancet"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J. Neurochem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijbiomac.2020.06.274","article-title":"Copper and iron ions accelerate the prion-like propagation of \u03b1-synuclein: A vicious cycle in Parkinson\u2019s disease","volume":"163","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_160","first-page":"633","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1471-4159.1981.tb01631.x","article-title":"Coupling of Dopamine Oxidation (Monoamine Oxidase Activity) to Glutathione Oxidation Via the Generation of Hydrogen Peroxide in Rat Brain Homogenates","volume":"36","author":"Maker","year":"1981","journal-title":"J. Neurochem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fnagi.2019.00106","article-title":"Regional High Iron in the Substantia Nigra Differentiates Parkinson\u2019s Disease Patients From Healthy Controls","volume":"11","author":"Ghassaban","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_163","first-page":"9163040","article-title":"The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson\u2019s Disease","volume":"2018","author":"Weng","year":"2018","journal-title":"Parkinson\u2019s Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1046\/j.1432-1327.2000.01595.x","article-title":"Glutathione, oxidative stress and neurodegeneration","volume":"267","author":"Schulz","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: Amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/bi0121353","article-title":"Vesicle Permeabilization by Protofibrillar \u03b1-Synuclein Is Sensitive to Parkinson\u2019s Disease-Linked Mutations and Occurs by a Pore-like Mechanism","volume":"41","author":"Volles","year":"2002","journal-title":"Biochemistry"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle Permeabilization by Protofibrillar \u03b1-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson\u2019s Disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","article-title":"Human \u03b1-Synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine","volume":"320","author":"Junn","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(02)01012-7","article-title":"The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect \u03b1-Synuclein Degradation and Parkinson\u2019s Disease Susceptibility","volume":"111","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson\u2019s disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/12647","article-title":"Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice","volume":"23","author":"Saigoh","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuint.2006.07.015","article-title":"Dopaminergic neuronal loss in transgenic mice expressing the Parkinson\u2019s disease-associated UCH-L1 I93M mutant","volume":"50","author":"Setsuie","year":"2007","journal-title":"Neurochem. Int."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","article-title":"Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/mds.22798","article-title":"The role of parkin in familial and sporadic Parkinson\u2019s disease","volume":"25","author":"Dawson","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1042\/BCJ20190676","article-title":"Interaction of \u03b1-synuclein and Parkin in iron toxicity on SH-SY5Y cells: Implications in the pathogenesis of Parkinson\u2019s disease","volume":"477","author":"Ganguly","year":"2020","journal-title":"Biochem. J."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1471-4159.2005.03023.x","article-title":"Alterations in the solubility and intracellular localization of parkin by several familial Parkinson\u2019s disease-linked point mutations","volume":"93","author":"Wang","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"47199","DOI":"10.1074\/jbc.M306769200","article-title":"Inactivation of Parkin by Oxidative Stress and C-terminal Truncations: A protective role of molecular chaperones","volume":"278","author":"Winklhofer","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000354307","article-title":"Parkin Plays a Role in Sporadic Parkinson\u2019s Disease","volume":"13","author":"Dawson","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.25135","article-title":"Living on the edge with too many mouths to feed: Why dopamine neurons die","volume":"27","author":"Bolam","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: From familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson\u2019s Disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1074\/jbc.M112.430801","article-title":"Characterization of PINK1 (PTEN-induced Putative Kinase 1) Mutations Associated with Parkinson Disease in Mammalian Cells and Drosophila","volume":"288","author":"Song","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/ejn.14689","article-title":"The contribution of Parkin, PINK1 and DJ-1 genes to selective neuronal degeneration in Parkinson\u2019s disease","volume":"52","author":"Havekes","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.redox.2014.04.010","article-title":"Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption","volume":"2","author":"Lopert","year":"2014","journal-title":"Redox Biol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4161\/auto.7.5.14684","article-title":"DJ-1 regulation of mitochondrial function and autophagy through oxidative stress","volume":"7","author":"McCoy","year":"2011","journal-title":"Autophagy"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fneur.2013.00038","article-title":"Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection","volume":"4","author":"Trempe","year":"2013","journal-title":"Front. Neurol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"alpha-Synuclein Is Localized to Mitochondria-Associated ER Membranes","volume":"34","author":"Liu","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","article-title":"Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson\u2019s Disease","volume":"19","author":"Hsieh","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: New Mechanistic Insights and Therapeutic Perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson\u2019s syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson\u2019s Disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2015.09.006","article-title":"Mitochondrial dysfunction associated with glucocerebrosidase deficiency","volume":"90","author":"Gegg","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone Suppression of alpha-Synuclein Toxicity in a Drosophila Model for Parkinson\u2019s Disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","article-title":"TorsinA and heat shock proteins act as molecular chaperones: Suppression of \u03b1-synuclein aggregation","volume":"83","author":"McLean","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.10-164624","article-title":"Heat-shock protein 70 modulates toxic extracellular \u03b1-synuclein oligomers and rescues trans-synaptic toxicity","volume":"25","author":"Danzer","year":"2011","journal-title":"FASEB J."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.109.158436","article-title":"Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent \u03b1-Synuclein Oligomer Formation and Rescue \u03b1-Synuclein-Induced Toxicity","volume":"332","author":"Putcha","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Joshi, N., Raveendran, A., and Nagotu, S. (2020). Chaperones and Proteostasis: Role in Parkinson\u2019s Disease. Diseases, 8.","DOI":"10.3390\/diseases8020024"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.arr.2016.09.004","article-title":"Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders","volume":"35","author":"Bose","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14740338.2014.931369","article-title":"Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson\u2019s disease","volume":"13","author":"Faulkner","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s13311-020-00889-4","article-title":"Medical Management and Prevention of Motor Complications in Parkinson\u2019s Disease","volume":"17","author":"Aradi","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/1871527316666170124165222","article-title":"Monoamine Oxidase B Inhibitors in Parkinson\u2019s Disease","volume":"16","author":"Dezsi","year":"2017","journal-title":"CNS Neurol. Disord.-Drug Targets"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-018-1869-1","article-title":"Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia","volume":"125","author":"Rascol","year":"2018","journal-title":"J. Neural Transm."},{"key":"ref_206","first-page":"114","article-title":"\u2019Bad guys\u2019 among the antiparkinsonian drugs","volume":"21","author":"Pirtosek","year":"2009","journal-title":"Psychiatr. Danub."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"862","DOI":"10.12688\/f1000research.25634.1","article-title":"Recent developments in the treatment of Parkinson\u2019s Disease","volume":"9","author":"Stoker","year":"2020","journal-title":"F1000Research"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaneurol.2018.1487","article-title":"Safety and Tolerability of Multiple Ascending Doses of PRX002\/RG7935, an Anti-alpha-Synuclein Monoclonal Antibody, in Patients with Parkinson Disease: A Randomized Clinical Trial","volume":"75","author":"Jankovic","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.26878","article-title":"First-in-human assessment of PRX002, an anti-\u03b1-synuclein monoclonal antibody, in healthy volunteers","volume":"32","author":"Schenk","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/brain\/awt224","article-title":"Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson\u2019s disease","volume":"136","author":"Mortiboys","year":"2013","journal-title":"Brain"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1212\/WNL.0000000000001905","article-title":"UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2G2019S carriers and In Vivo","volume":"85","author":"Mortiboys","year":"2015","journal-title":"Neurology"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","article-title":"Parkinson\u2019s disease treatment: Past, present, and future","volume":"127","author":"Elsworth","year":"2020","journal-title":"J. Neural Transm."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the Treatment of Patients with Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s43440-020-00120-3","article-title":"Neurotrophic factors for disease-modifying treatments of Parkinson\u2019s disease: Gaps between basic science and clinical studies","volume":"72","author":"Chmielarz","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson\u2019s Disease: Dawn of a New Era","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443738","article-title":"The Prevalence of Huntington\u2019s Disease","volume":"46","author":"Rawlins","year":"2016","journal-title":"Neuroepidemiology"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/WCO.0b013e3283550c97","article-title":"Huntington\u2019s disease","volume":"25","author":"Ha","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11920-017-0759-9","article-title":"Juvenile Huntington\u2019s Disease: Diagnostic and Treatment Considerations for the Psychiatrist","volume":"19","author":"Quigley","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-170235","article-title":"Is Huntingtin Dispensable in the Adult Brain?","volume":"6","author":"Liu","year":"2017","journal-title":"J. Huntington\u2019s Dis."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1100\/tsw.2008.60","article-title":"The Ubiquitin-Proteasome Pathway in Huntington\u2019s Disease","volume":"8","author":"Mitra","year":"2008","journal-title":"Sci. World J."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.jmb.2019.11.012","article-title":"Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington\u2019s Disease","volume":"432","author":"Valionyte","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuron.2017.03.027","article-title":"Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport","volume":"94","author":"Goginashvili","year":"2017","journal-title":"Neuron"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fmolb.2019.00020","article-title":"Protein Misfolding and ER Stress in Huntington\u2019s Disease","volume":"6","author":"Shacham","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jnc.14853","article-title":"The pathobiology of perturbed mutant huntingtin protein\u2013protein interactions in Huntington\u2019s disease","volume":"151","author":"Wanker","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12640-017-9766-1","article-title":"Huntington\u2019s Disease and Mitochondria","volume":"32","author":"Farshbaf","year":"2017","journal-title":"Neurotox. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","article-title":"Mitochondrial Dysfunction in Huntington\u2019s Disease","volume":"1049","author":"Carmo","year":"2018","journal-title":"Polyglutamine Disord."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Koyuncu, S., Fatima, A., Gutierrez-Garcia, R., and Vilchez, D. (2017). Proteostasis of Huntingtin in Health and Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071568"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Bohush, A., Bieganowski, P., and Filipek, A. (2019). Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20204976"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11910-017-0739-9","article-title":"Huntington\u2019s Disease\u2014Update on Treatments","volume":"17","author":"Wyant","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-381328-2.00013-4","article-title":"Huntington\u2019s Disease: Clinical Presentation and Treatment","volume":"98","author":"Novak","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/14737175.2019.1631161","article-title":"Emerging therapies in Huntington\u2019s disease","volume":"19","author":"Bashir","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JHD-200002","article-title":"Huntington\u2019s Disease Clinical Trials Corner: April 2020","volume":"9","author":"Rodrigues","year":"2020","journal-title":"J. Huntington\u2019s Dis."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00401-017-1708-8","article-title":"Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis","volume":"133","author":"Nijssen","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"ref_239","first-page":"57","article-title":"Variation in worldwide incidence of amyotrophic lateral sclerosis: A meta-analysis","volume":"46","author":"Marin","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: An update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.4130","article-title":"The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41525-020-00139-8","article-title":"Identity by descent analysis identifies founder events and links SOD1 familial and sporadic ALS cases","volume":"5","author":"Henden","year":"2020","journal-title":"NPJ Genom. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"238.e25","DOI":"10.1016\/j.neurobiolaging.2019.04.012","article-title":"The role of C9orf72 in neurodegenerative disorders: A systematic review, an updated meta-analysis, and the creation of an online database","volume":"84","author":"Marogianni","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/156720511795563700","article-title":"FTD and ALS: A Tale of Two Diseases","volume":"8","author":"Ferrari","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"Mackenzie","year":"2011","journal-title":"Neuron"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.conb.2011.05.029","article-title":"Understanding the role of TDP-43 and FUS\/TLS in ALS and beyond","volume":"21","author":"Cleveland","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","article-title":"Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis","volume":"577","author":"Kaur","year":"2016","journal-title":"Gene"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Boyd, S.D., Ullrich, M.S., Calvo, J.S., Behnia, F., Meloni, G., and Winkler, D.D. (2020). Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs). Molecules, 25.","DOI":"10.3390\/molecules25051086"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fnins.2016.00499","article-title":"Susceptibility of Mutant SOD1 to Form a Destabilized Monomer Predicts Cellular Aggregation and Toxicity but Not In Vitro Aggregation Propensity","volume":"10","author":"McAlary","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/s41598-019-43164-z","article-title":"SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS","volume":"9","author":"Gill","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fncel.2015.00336","article-title":"SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis","volume":"9","author":"Tafuri","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2174\/1568026611212220010","article-title":"SOD1 aggregation and ALS: Role of metallation states and disulfide status","volume":"12","author":"Sheng","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1073\/pnas.1801109115","article-title":"Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis","volume":"115","author":"Medinas","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00401-016-1601-x","article-title":"ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics","volume":"132","author":"Gal","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2015.02.034","article-title":"Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1","volume":"86","author":"Israelson","year":"2015","journal-title":"Neuron"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Tak, Y.J., Park, J.-H., Rhim, H., and Kang, S. (2020). ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207525"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12035-009-8054-3","article-title":"ER stress and unfolded protein response in amyotrophic lateral sclerosis","volume":"39","author":"Kanekura","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1101\/gad.1640108","article-title":"ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1","volume":"22","author":"Nishitoh","year":"2008","journal-title":"Genes Dev."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1046\/j.1471-4159.2002.01211.x","article-title":"Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis","volume":"83","author":"Urushitani","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"E8294","DOI":"10.1073\/pnas.1704294114","article-title":"Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS","volume":"114","author":"Rudnick","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1073\/pnas.1312245111","article-title":"Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms","volume":"111","author":"Grad","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00401-018-1915-y","article-title":"Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis","volume":"136","author":"Bidhendi","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2014.01.007","article-title":"Structural characterization of the minimal segment of TDP-43 competent for aggregation","volume":"545","author":"Buratti","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.molmed.2011.06.004","article-title":"TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies","volume":"17","author":"Cohen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmb.2005.02.038","article-title":"Human, Drosophila, and C. elegans TDP43: Nucleic acid binding properties and splicing regulatory function","volume":"348","author":"Ayala","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.adgen.2015.07.001","article-title":"Functional Significance of TDP-43 Mutations in Disease","volume":"91","author":"Buratti","year":"2015","journal-title":"Adv. Genet."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/1873-3468.12646","article-title":"TDP-43 and FUS en route from the nucleus to the cytoplasm","volume":"591","author":"Ederle","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/emboj.2010.310","article-title":"TDP-43 regulates its mRNA levels through a negative feedback loop","volume":"30","author":"Ayala","year":"2011","journal-title":"EMBO J."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1073\/pnas.0912417107","article-title":"TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration","volume":"107","author":"Wils","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1073\/pnas.0913602107","article-title":"A Drosophila model for TDP-43 proteinopathy","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/hmg\/ddq230","article-title":"Neurotoxic effects of TDP-43 overexpression in C. elegans","volume":"19","author":"Ash","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1038\/s41598-018-25767-0","article-title":"TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types","volume":"8","author":"Khalfallah","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"41310","DOI":"10.1074\/jbc.M112.398099","article-title":"Roles of Ataxin-2 in Pathological Cascades Mediated by TAR DNA-binding Protein 43 (TDP-43) and Fused in Sarcoma (FUS)","volume":"287","author":"Nihei","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neuron.2019.05.048","article-title":"Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS\/FTD","volume":"103","author":"Fang","year":"2019","journal-title":"Neuron"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"23079","DOI":"10.1074\/jbc.M111.328757","article-title":"Requirements for Stress Granule Recruitment of Fused in Sarcoma (FUS) and TAR DNA-binding Protein of 43 kDa (TDP-43)","volume":"287","author":"Bentmann","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1074\/jbc.RA118.007222","article-title":"The role of liquid\u2013liquid phase separation in aggregation of the TDP-43 low-complexity domain","volume":"294","author":"Babinchak","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cell.2012.04.017","article-title":"Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels","volume":"149","author":"Kato","year":"2012","journal-title":"Cell"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.str.2016.07.007","article-title":"ALS Mutations Disrupt Phase Separation Mediated by \u03b1-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain","volume":"24","author":"Conicella","year":"2016","journal-title":"Structure"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cell.2015.07.047","article-title":"A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation","volume":"162","author":"Patel","year":"2015","journal-title":"Cell"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","article-title":"Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies","volume":"117","author":"Neumann","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","article-title":"Abnormal phosphorylation of Ser409\/410 of TDP-43 in FTLD-U and ALS","volume":"582","author":"Inukai","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14728222.2018.1439923","article-title":"TDP-43 post-translational modifications in health and disease","volume":"22","author":"Buratti","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.21425","article-title":"Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"64","author":"Hasegawa","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1074\/jbc.M809462200","article-title":"Expression of TDP-43 C-terminal Fragments In Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies","volume":"284","author":"Igaz","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"18845","DOI":"10.1074\/jbc.M111.231118","article-title":"A \u201cTwo-hit\u201d Hypothesis for Inclusion Formation by Carboxyl-terminal Fragments of TDP-43 Protein Linked to RNA Depletion and Impaired Microtubule-dependent Transport","volume":"286","author":"Pesiridis","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/mt.2013.88","article-title":"Selective Forelimb Impairment in Rats Expressing a Pathological TDP-43 25 kDa C-terminal Fragment to Mimic Amyotrophic Lateral Sclerosis","volume":"21","author":"Dayton","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1093\/hmg\/ddv193","article-title":"Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43","volume":"24","author":"Caccamo","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ajpath.2011.09.022","article-title":"Cognitive Decline Typical of Frontotemporal Lobar Degeneration in Transgenic Mice Expressing the 25-kDa C-Terminal Fragment of TDP-43","volume":"180","author":"Caccamo","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnins.2019.00335","article-title":"The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD","volume":"13","author":"Berning","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_295","first-page":"1263","article-title":"Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species","volume":"127","author":"Scotter","year":"2014","journal-title":"J. Cell Sci."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"1779.e5","DOI":"10.1016\/j.neurobiolaging.2014.01.016","article-title":"Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion","volume":"35","author":"Waite","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"a024224","DOI":"10.1101\/cshperspect.a024224","article-title":"Disease Mechanisms of C9ORF72 Repeat Expansions","volume":"8","author":"Gendron","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3233\/JAD-131028","article-title":"C9ORF72 Hexanucleotide Repeat Number in Frontotemporal Lobar Degeneration: A Genotype-Phenotype Correlation Study","volume":"38","author":"Benussi","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/hmg\/ddt460","article-title":"Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"23","author":"Icardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-015-1445-9","article-title":"Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration","volume":"130","author":"Suh","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat. Med."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/brain\/awu120","article-title":"Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions","volume":"137","author":"Walsh","year":"2014","journal-title":"Brain"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00401-017-1725-7","article-title":"In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers","volume":"134","author":"Finch","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1254917","article-title":"Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells","volume":"345","author":"Kwon","year":"2014","journal-title":"Science"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/hmg\/ddv005","article-title":"Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity","volume":"24","author":"Tao","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: Multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","article-title":"p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND\/ALS","volume":"122","author":"King","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1440-1789.2012.01332.x","article-title":"Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: Clinicopathologic correlation","volume":"33","author":"Bigio","year":"2013","journal-title":"Neuropathology"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/bioinformatics\/bts725","article-title":"The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs","volume":"29","author":"Levine","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.15252\/embj.201593350","article-title":"Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death","volume":"35","author":"Sellier","year":"2016","journal-title":"EMBO J."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(11)70261-7","article-title":"A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study","volume":"11","author":"Gijselinck","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41593-020-0619-5","article-title":"Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72","volume":"23","author":"Zhu","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/srep01016","article-title":"C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes","volume":"2","author":"Fratta","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","article-title":"C9orf72 nucleotide repeat structures initiate molecular cascades of disease","volume":"507","author":"Haeusler","year":"2014","journal-title":"Nature"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neuron.2015.09.015","article-title":"Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD\/ALS","volume":"87","author":"Tran","year":"2015","journal-title":"Neuron"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00401-015-1476-2","article-title":"Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers","volume":"130","author":"MacKenzie","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00401-014-1336-5","article-title":"Aggregation-prone c9FTD\/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress","volume":"128","author":"Zhang","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/2051-5960-1-68","article-title":"Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72","volume":"1","author":"Mann","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1074\/jbc.M115.694273","article-title":"The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties","volume":"291","author":"Chang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-014-1329-4","article-title":"C9orf72 FTLD\/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration","volume":"128","author":"May","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1256800","article-title":"C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins","volume":"345","author":"Mizielinska","year":"2014","journal-title":"Science"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nn.4085","article-title":"Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD\/ALS","volume":"18","author":"Mertens","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnmol.2017.00035","article-title":"The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD","volume":"10","author":"Freibaum","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fmolb.2018.00044","article-title":"Importance of Functional Loss of FUS in FTLD\/ALS","volume":"5","author":"Ishigaki","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"e40811","DOI":"10.7554\/eLife.40811","article-title":"Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis","volume":"8","author":"Ling","year":"2019","journal-title":"eLife"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.15252\/embj.201797568","article-title":"Dysregulated molecular pathways in amyotrophic lateral sclerosis\u2013frontotemporal dementia spectrum disorder","volume":"36","author":"Gao","year":"2017","journal-title":"EMBO J."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.15252\/embj.201592559","article-title":"Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss","volume":"35","author":"Sendscheid","year":"2016","journal-title":"EMBO J."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbrc.2016.02.107","article-title":"Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2","volume":"472","author":"Osaka","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"P4.431","DOI":"10.1212\/WNL.90.15_supplement.P4.431","article-title":"Low expression of mutant Ubiquilin-2 exacerbates ALS\/FTD features in a TDP-43 mouse model (P4.431)","volume":"90","author":"Julien","year":"2018","journal-title":"Neurology"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13041-017-0287-x","article-title":"TBK1: A new player in ALS linking autophagy and neuroinflammation","volume":"10","author":"Oakes","year":"2017","journal-title":"Mol. Brain"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.cell.2018.07.041","article-title":"TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging","volume":"174","author":"Xu","year":"2018","journal-title":"Cell"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.18632\/aging.101936","article-title":"Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice","volume":"11","author":"Duan","year":"2019","journal-title":"Aging"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nn.4000","article-title":"Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia","volume":"18","author":"Freischmidt","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"1602.e17","DOI":"10.1016\/j.neurobiolaging.2014.10.032","article-title":"Novel mutations support a role for Profilin 1 in the pathogenesis of ALS","volume":"36","author":"Smith","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"E6209","DOI":"10.1073\/pnas.1605964113","article-title":"Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature11280","article-title":"Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis","volume":"488","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/hmg\/ddw024","article-title":"Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation","volume":"25","author":"Tanaka","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nbd.2009.05.002","article-title":"The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis","volume":"35","author":"Wang","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0705046104","article-title":"Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity","volume":"104","author":"Bogaert","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/emboj.2013.122","article-title":"Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats","volume":"32","author":"Tong","year":"2013","journal-title":"EMBO J."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41418-018-0060-4","article-title":"Exploring the genetics and non-cell autonomous mechanisms underlying ALS\/FTLD","volume":"25","author":"Chen","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity","volume":"8","author":"Dobrowolny","year":"2008","journal-title":"Cell Metab."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"592851","DOI":"10.3389\/fneur.2020.592851","article-title":"Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome","volume":"11","author":"Martin","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","article-title":"The \u201cDying-Back\u201d Phenomenon of Motor Neurons in ALS","volume":"43","author":"Melamed","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"ref_347","doi-asserted-by":"crossref","unstructured":"Scaricamazza, S., Salvatori, I., Ferri, A., and Valle, C. (2021). Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?. Cells, 10.","DOI":"10.3390\/cells10030525"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10930-019-09824-9","article-title":"Exploring the Extended Biological Functions of the Human Copper Chaperone of Superoxide Dismutase 1","volume":"38","author":"Ge","year":"2019","journal-title":"Protein J."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1042\/BST20200318","article-title":"Molecular and pharmacological chaperones for SOD1","volume":"48","author":"Wright","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41593-019-0530-0","article-title":"Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein","volume":"22","author":"Farhan","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnmol.2017.00176","article-title":"The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases","volume":"10","author":"Rusmini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2017.06.021","article-title":"Macrophage migration inhibitory factor: A multifaceted cytokine implicated in multiple neurological diseases","volume":"301","author":"Kahn","year":"2018","journal-title":"Exp. Neurol."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1073\/pnas.1604600113","article-title":"Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS","volume":"113","author":"Benaim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"14755","DOI":"10.1073\/pnas.1904665116","article-title":"AAV2\/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS","volume":"116","author":"Kahn","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/chem.201904292","article-title":"A Lipophilic 4-Phenylbutyric Acid Derivative That Prevents Aggregation and Retention of Misfolded Proteins","volume":"26","author":"Trobiani","year":"2020","journal-title":"Chemistry"},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s43440-021-00226-2","article-title":"Chemical chaperones targeted to the endoplasmic reticulum (ER) and lysosome prevented neurodegeneration in a C9orf72 repeat expansion Drosophila amyotrophic lateral sclerosis (ALS) model","volume":"73","author":"Weitman","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/00003495-199652040-00010","article-title":"Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis","volume":"52","author":"Bryson","year":"1996","journal-title":"Drugs"},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awl024","article-title":"Altered axonal excitability properties in amyotrophic lateral sclerosis: Impaired potassium channel function related to disease stage","volume":"129","author":"Kanai","year":"2006","journal-title":"Brain"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/nbdi.2000.0297","article-title":"A Novel Neuroprotective Mechanism of Riluzole: Direct Inhibition of Protein Kinase C","volume":"7","author":"Noh","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"ref_360","doi-asserted-by":"crossref","unstructured":"Amyotrophic Lateral Sclerosis\/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V., Leigh, P., and Guillet, P. (1996). Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet, 347, 1425\u20131431.","DOI":"10.1016\/S0140-6736(96)91680-3"},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cell.2017.10.011","article-title":"Edaravone: A new drug approved for ALS","volume":"171","author":"Rothstein","year":"2017","journal-title":"Cell"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuint.2015.07.024","article-title":"Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress","volume":"90","author":"Jami","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/acn3.567","article-title":"Long-term Phase 1\/2 intraspinal stem cell transplantation outcomes in ALS","volume":"5","author":"Goutman","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","article-title":"Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients with Amyotrophic Lateral Sclerosis: Results of Phase 1\/2 and 2a Clinical Trials","volume":"73","author":"Petrou","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678421.2019.1632346","article-title":"Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A randomized clinical trial","volume":"21","author":"Mora","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_367","first-page":"327","article-title":"A promising new therapy for ALS","volume":"17","author":"Wood","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ene.12691","article-title":"The TUDCA trial\u2014Innovative trial designs for amyotrophic lateral sclerosis drugs?","volume":"23","author":"Ludolph","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1212\/WNL.0000000000004960","article-title":"Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS","volume":"90","author":"Benatar","year":"2018","journal-title":"Neurology"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00415-011-6104-z","article-title":"The role of mitochondria in neurodegenerative diseases","volume":"258","author":"Filosto","year":"2011","journal-title":"J. Neurol."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-016-1296-4","article-title":"The role of endoplasmic reticulum stress in neurodegenerative disease","volume":"22","author":"Xiang","year":"2017","journal-title":"Apoptosis"},{"key":"ref_372","first-page":"131","article-title":"ER Stress and Neurodegenerative Disease: A Cause or Effect Relationship?","volume":"414","author":"Hetz","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_373","first-page":"19","article-title":"A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases","volume":"118","author":"Borza","year":"2014","journal-title":"Med -Surg. J."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejmech.2016.07.054","article-title":"Protein aggregation and neurodegenerative diseases: From theory to therapy","volume":"124","author":"Kumar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non\u2013cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/9\/2438\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:00:35Z","timestamp":1760166035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/9\/2438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":375,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["cells10092438"],"URL":"https:\/\/doi.org\/10.3390\/cells10092438","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]}}}